Reduces hyperlipidemia‐induced cardiac damages by Suppressing lipid deposition (LOX‐1 and CD36) and cardiac fibrosis (MMP2, MMP9, collagen I, collagen III, and TGF‐β). The gene discussed is OLR1; the disease is fibrosis.